Skip to content
2000
  1. Home
  2. A-Z Publications
  3. New Emirates Medical Journal
  4. Volume 5, Issue 1
  5. Article
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
side by side viewer icon HTML

Abstract

A lot of athletes, bodybuilders, and those who want to look better in general use AAS (anabolic androgenic steroids) to achieve their goals. These steroids can be found in nature or synthesised in a lab. These substances are attempts to mimic the anabolic (muscle-building) and androgenic (masculinizing) properties of testosterone. Steroids like testosterone, methandienone, Nandrolone Decanoate (ND), and methenolone are only a few examples of AAS that are commonly abused. Initially exclusive to professional bodybuilders, these substances are increasingly being tried out by amateur and professional athletes alike. The anabolic properties of AAS have led to their usage in medicine for the treatment of conditions like chronic renal disease and osteoporosis in postmenopausal women. Despite being banned by the World Anti-Doping Agency, anabolic steroid (AAS) use is estimated to be between 1% and 3% among the general population of the United States (WADA). Their negative effects on several organs, including the cardiovascular and reproductive systems, have aroused concerns. Therefore, there are serious health risks linked with the inappropriate use of AAS. More education is needed for both the general public and medical professionals on how to recognise symptoms, administer effective care, and prevent AAS-related disorders. The goal of this study is to examine the current state of our understanding regarding the functioning of AAS and their associated deleterious consequences.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882253706240104073440
2024-02-27
2025-04-06

  • From This Site

    /content/journals/nemj/10.2174/0102506882253706240104073440
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. RomanM. RomanD.L. OstafeV. CiorsacA. IsvoranA. Computational assessment of pharmacokinetics and biological effects of some anabolic and androgen steroids.Pharm. Res.20183524110.1007/s11095‑018‑2353‑129404794
     [Google Scholar]
  2. AlbanoG.D. Adverse effects of anabolic-androgenic steroids: A literature review.Healthcare.20219197
     [Google Scholar]
  3. AnawaltB.D. Diagnosis and management of anabolic androgenic steroid use.J. Clin. Endocrinol. Metab.201910472490250010.1210/jc.2018‑0188230753550
     [Google Scholar]
  4. PatanèF.G. LibertoA. Maria MaglittoA.N. MalandrinoP. EspositoM. AmicoF. CocimanoG. RosiG.L. CondorelliD. NunnoN.D. MontanaA. Nandrolone decanoate: Use, abuse and side effects.Medicina2020561160610.3390/medicina5611060633187340
     [Google Scholar]
  5. WeberA.E. Anabolic androgenic steroids in orthopaedic surgery: Current concepts and clinical applications.JAAOS Global Res. Rev.202261e21.0015610.5435/JAAOSGlobal‑D‑21‑00156
     [Google Scholar]
  6. MullenC. WhalleyB.J. SchifanoF. BakerJ.S. Anabolic androgenic steroid abuse in the United Kingdom: An update.Br. J. Pharmacol.2020177102180219810.1111/bph.1499531989581
     [Google Scholar]
  7. Moura SantosA. Silva LippoB.R. BahrkeM.S. YonamineM. Patterns of anabolic-androgenic steroid use, aesthetic doping, and body imagewithin the male Brazilian bodybuilding culture: an ethnographic approach.Int. J. Complement. Altern. Med.2023162798610.15406/ijcam.2023.16.00635
     [Google Scholar]
  8. RossoD.F.M. de Moraes FischerR. KusmD.F. Use of androgenic anabolic steroids in resistance exercise practitioners in the gyms of the city of Palotina-Pr, Brazil.Int. J. Dev. Res.202010073813638141
     [Google Scholar]
  9. BasariaS. Androgen abuse in athletes: Detection and consequences.J. Clin. Endocrinol. Metab.20109541533154310.1210/jc.2009‑157920139230
     [Google Scholar]
  10. El OstaR. AlmontT. DiligentC. HubertN. EschwègeP. HubertJ. Anabolic steroids abuse and male infertility.Basic Clin. Androl.2016261210.1186/s12610‑016‑0029‑426855782
     [Google Scholar]
  11. BhasinS. HatfieldD.L. HoffmanJ.R. KraemerW.J. LabotzM. PhillipsS.M. RatamessN.A. Anabolic-androgenic steroid use in sports, health, and society.Med. Sci. Sports Exerc.20215381778179410.1249/MSS.000000000000267034261998
     [Google Scholar]
  12. HearneE. WazaifyM. Van HoutM.C. AtkinsonA. McVeighJ. Anabolic-androgenic steroid use in the Eastern Mediterranean region: A scoping review of extant empirical literature.Int. J. Ment. Health Addict.20211941162118910.1007/s11469‑019‑00217‑8
     [Google Scholar]
  13. MenafraD. Osteoporosis: May doping cause It?Male Osteoporosis, Gender Differences in Pathophysiology, Clinical Aspects, Diagnosis and Treatment.SpringerFerlin A. Migliaccio S.20201637310.1007/978‑3‑319‑96376‑1_15
     [Google Scholar]
  14. InvernizziM. de SireA. RenòF. CisariC. RunzaL. BaricichA. CardaS. FuscoN. Spinal cord injury as a model of bone-muscle interactions: Therapeutic implications from in vitro and in vivo studies.Front. Endocrinol.20201120410.3389/fendo.2020.0020432351450
     [Google Scholar]
  15. JosephJ. ParrM. Synthetic androgens as designer supplements.Curr. Neuropharmacol.20151318910010.2174/1570159X1366614121022475626074745
     [Google Scholar]
  16. Breenfeldt AndersenA. JacobsonG.A. BejderJ. PremilovacD. RichardsS.M. RasmussenJ.J. JessenS. HostrupM. An abductive inference approach to assess the performance-enhancing effects of drugs included on the World Anti-Doping Agency prohibited list.Sports Med.20215171353137610.1007/s40279‑021‑01450‑933811295
     [Google Scholar]
  17. AnawaltB.D. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.Mol. Cell. Endocrinol.2018464212710.1016/j.mce.2017.09.02728943276
     [Google Scholar]
  18. Domínguez-LópezI. Yago-AragónM. Salas-HuetosA. Tresserra-RimbauA. Hurtado-BarrosoS. Effects of dietary phytoestrogens on hormones throughout a human lifespan: A review.Nutrients2020128245610.3390/nu1208245632824177
     [Google Scholar]
  19. HakanssonA. MickelssonK. WallinC. BerglundM. Anabolic androgenic steroids in the general population: User characteristics and associations with substance use.Eur. Addict. Res.2012182839010.1159/00033303722286840
     [Google Scholar]
  20. KanayamaG. KaufmanM.J. PopeH.G.Jr Public health impact of androgens.Curr. Opin. Endocrinol. Diabetes Obes.201825321822310.1097/MED.000000000000040429369918
     [Google Scholar]
  21. HopeV.D. Walker BondV. BoardleyI. SmithJ. CampbellJ. BatesG. RalphsR. Van HoutM-C. McVeighJ. Anabolic androgenic steroid use population size estimation: A first stage study utilising a Delphi exercise.Drugs Educ. Prev. Policy202330546147310.1080/09687637.2022.2070058
     [Google Scholar]
  22. BonnecazeA.K. O’ConnorT. AloiJ.A. Characteristics and attitudes of men using anabolic androgenic steroids (AAS): A survey of 2385 men.Am. J. Men Health202014(6).10.1177/155798832096653633307930
     [Google Scholar]
  23. RahnemaC.D. CrosnoeL.E. KimE.D. Designer steroids - over-the-counter supplements and their androgenic component: Review of an increasing problem.Andrology20153215015510.1111/andr.30725684733
     [Google Scholar]
  24. AlthobitiS. AlqurashiN. AlotaibiA. AlharthiT. AlswatK. Prevalence, attitude, knowledge, and practice of anabolic androgenic steroid (AAS) use among gym participants.Mater. Sociomed.2018301495210.5455/msm.2018.30.49‑5229670477
     [Google Scholar]
  25. ChristoffersenT. AndersenJ.T. DalhoffK.P. HorwitzH. Anabolic-androgenic steroids and the risk of imprisonment.Drug Alcohol Depend.2019203929710.1016/j.drugalcdep.2019.04.04131421475
     [Google Scholar]
  26. BondP. SmitD.L. de RondeW. Anabolic–androgenic steroids: How do they work and what are the risks?Front. Endocrinol.202213105947310.3389/fendo.2022.105947336644692
     [Google Scholar]
  27. de RondeW. SmitD.L. Anabolic androgenic steroid abuse in young males.Endocr. Connect.202094R102R11110.1530/EC‑19‑055732229704
     [Google Scholar]
  28. HarveyO. Male anabolic androgenic steroid-users: A mixed-methods study. The voice of the AAS-user.Bournemouth University2020
     [Google Scholar]
  29. KanayamaG. HudsonJ.I. PopeH.G.Jr Illicit anabolic–androgenic steroid use.Horm. Behav.201058111112110.1016/j.yhbeh.2009.09.00619769977
     [Google Scholar]
  30. RowanM. Mental Health Concerns in Athletes.Psychological Considerations in the Young Athlete Contemporary Pediatric and Adolescent Sports Medicine.Springer2023215810.1007/978‑3‑031‑25126‑9_2
     [Google Scholar]
  31. ChristinoM.A. PluharE.I. MicheliL.J. Psychological Considerations in the Young Athlete: A Multidisciplinary Approach.Springer2023ixiii26510.1007/978‑3‑031‑25126‑9
     [Google Scholar]
  32. KicmanA.T. Pharmacology of anabolic steroids.Br. J. Pharmacol.2008154350252110.1038/bjp.2008.16518500378
     [Google Scholar]
  33. SessaF. SalernoM. Di MizioG. BertozziG. MessinaG. TomaiuoloB. PisanelliD. MagliettaF. RicciP. PomaraC. Anabolic androgenic steroids: Searching new molecular biomarkers.Front. Pharmacol.20189132110.3389/fphar.2018.0132130524281
     [Google Scholar]
  34. AlsiöJ. BirgnerC. BjörkblomL. IsakssonP. BergströmL. SchiöthH.B. LindblomJ. Impact of nandrolone decanoate on gene expression in endocrine systems related to the adverse effects of anabolic androgenic steroids.Basic Clin. Pharmacol. Toxicol.2009105530731410.1111/j.1742‑7843.2009.00439.x19549128
     [Google Scholar]
  35. CheungA.S. GrossmannM. Physiological basis behind ergogenic effects of anabolic androgens.Mol. Cell. Endocrinol.2018464142010.1016/j.mce.2017.01.04728159654
     [Google Scholar]
  36. FortunatoR.S. MarassiM.P. ChavesE.A. NascimentoJ.H.M. RosenthalD. CarvalhoD.P. Chronic administration of anabolic androgenic steroid alters murine thyroid function.Med. Sci. Sports Exerc.200638225626110.1249/01.mss.0000183357.19743.5116531893
     [Google Scholar]
  37. NieschlagE. VoronaE. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.Rev. Endocr. Metab. Disord.201516319921110.1007/s11154‑015‑9320‑526373946
     [Google Scholar]
  38. GeraldT. RajG. Testosterone and the androgen receptor.Urologic Clinics202249460361436309417
     [Google Scholar]
  39. MonksD.A. HolmesM.M. Androgen receptors and muscle: A key mechanism underlying life history trade-offs.J. Comp. Physiol. A Neuroethol. Sens. Neural Behav. Physiol.20182041516010.1007/s00359‑017‑1222‑429063284
     [Google Scholar]
  40. AraziH. MohammadjafariH. AsadiA. Use of anabolic androgenic steroids produces greater oxidative stress responses to resistance exercise in strength-trained men.Toxicol. Rep.2017428228610.1016/j.toxrep.2017.05.00528959650
     [Google Scholar]
  41. NorrisS.A. FrongilloE.A. BlackM.M. DongY. FallC. LamplM. LieseA.D. NaguibM. PrenticeA. RochatT. StephensenC.B. TinagoC.B. WardK.A. WrottesleyS.V. PattonG.C. Nutrition in adolescent growth and development.Lancet20223991032017218410.1016/S0140‑6736(21)01590‑734856190
     [Google Scholar]
  42. Marin-PuyaltoJ. MäestuJ. Gomez-CabelloA. LättE. RemmelL. PurgeP. CasajúsJ.A. Vicente-RodríguezG. JürimäeJ. Vigorous physical activity patterns affect bone growth during early puberty in boys.Osteoporos. Int.201829122693270110.1007/s00198‑018‑4731‑230334092
     [Google Scholar]
  43. DhankharS. ChauhanS. MehtaD.K. Nitika SainiK. SainiM. DasR. GuptaS. GautamV. Novel targets for potential therapeutic use in Diabetes mellitus.Diabetol. Metab. Syndr.20231511710.1186/s13098‑023‑00983‑536782201
     [Google Scholar]
  44. FrankenfeldS.P. OliveiraL.P. OrtenziV.H. Rego-MonteiroI.C.C. ChavesE.A. FerreiraA.C. LeitãoA.C. CarvalhoD.P. FortunatoR.S. The anabolic androgenic steroid nandrolone decanoate disrupts redox homeostasis in liver, heart and kidney of male Wistar rats.PLoS One201499e10269910.1371/journal.pone.010269925225984
     [Google Scholar]
  45. FrankenfeldS.P. de OliveiraL.P. IgnacioD.L. CoelhoR.G. MattosM.N. FerreiraA.C.F. CarvalhoD.P. FortunatoR.S. Nandrolone decanoate inhibits gluconeogenesis and decreases fasting glucose in Wistar male rats.J. Endocrinol.2014220214315310.1530/JOE‑13‑025924403377
     [Google Scholar]
  46. ChavesE.A. Pereira-JuniorP.P. FortunatoR.S. MasudaM.O. de CarvalhoA.C.C. de CarvalhoD.P. OliveiraM.F. NascimentoJ.H.M. Nandrolone decanoate impairs exercise-induced cardioprotection: Role of antioxidant enzymes.J. Steroid Biochem. Mol. Biol.2006994-522323010.1016/j.jsbmb.2006.01.00416621517
     [Google Scholar]
  47. CerretaniD. NeriM. CantatoreS. CiallellaC. RiezzoI. TurillazziE. FineschiV. Looking for organ damages due to anabolic-androgenic steroids (AAS): Is oxidative stress the culprit?Mini Rev. Org. Chem.201310439339910.2174/1570193X113106660025
     [Google Scholar]
  48. MittalP. DhankharS. ChauhanS. GargN. BhattacharyaT. AliM. ChaudharyA.A. RudayniH.A. Al-ZharaniM. AhmadW. KhanS.U.D. SinghT.G. MujwarS. A review on natural antioxidants for their role in the treatment of parkinson’s disease.Pharmaceuticals202316790810.3390/ph1607090837513820
     [Google Scholar]
  49. NarwalS. DhandaT. SharmaP. SharmaV. DhankharS. GargN. GhoshN.S. RaniN. Current therapeutic strategies for chagas disease.Antiinfect. Agents20232111110.2174/2211352521666230823122601
     [Google Scholar]
  50. ChauhanS. Antihyperglycemic and antioxidant potential of plant extract of litchi chinensis and glycine max.Int. J. Nutr. Pharmacol. Neurol. Dis.2021113225233
     [Google Scholar]
  51. GuptaS. BurmanS. NairA.B. ChauhanS. SircarD. RoyP. DhanwatM. LahiriD. MehtaD. DasR. KhalilH.E. Brassica oleracea extracts prevent hyperglycemia in type 2 diabetes mellitus.Prev. Nutr. Food Sci.2022271506210.3746/pnf.2022.27.1.5035465108
     [Google Scholar]
  52. BaratiE. NikzadH. KarimianM. Oxidative stress and male infertility: Current knowledge of pathophysiology and role of antioxidant therapy in disease management.Cell. Mol. Life Sci.20207719311310.1007/s00018‑019‑03253‑831377843
     [Google Scholar]
  53. YangF.L. WeiY.X. LiaoB.Y. WeiG.J. QinH.M. PangX.X. WangJ.L. Effects of Lycium barbarum polysaccharide on endoplasmic reticulum stress and oxidative stress in obese mice.Front. Pharmacol.20201174210.3389/fphar.2020.0074232528287
     [Google Scholar]
  54. ZhangY. DingH. XuL. ZhaoS. HuS. MaA. MaY. Lutein can alleviate oxidative stress, inflammation, and apoptosis induced by excessive alcohol to ameliorate reproductive damage in male rats.Nutrients20221412238510.3390/nu1412238535745115
     [Google Scholar]
  55. TurillazziE. NeriM. CerretaniD. CantatoreS. FratiP. MoltoniL. BusardòF.P. PomaraC. RiezzoI. FineschiV. Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: The mutual crosstalk between ROS and NF - kB.J. Cell. Mol. Med.201620460161210.1111/jcmm.1274826828721
     [Google Scholar]
  56. RohillaM. Rishabh BansalS. GargA. DhimanS. DhankharS. SainiM. ChauhanS. AlsubaieN. BatihaG.E.S. AlbezrahN.K.A. SinghT.G. Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy.Biomed. Pharmacother.202316911588110.1016/j.biopha.2023.11588137989030
     [Google Scholar]
  57. SaharanR. KaurJ. DhankharS. GargN. ChauhanS. KumarS. SharmaH. Hydrogel-based drug delivery system in diabetes management.Pharm. Nanotechnol.20231211110.2174/012211738526627623092806423537818559
     [Google Scholar]
  58. SharmaS. KumariN. GargD. ChauhanS. A compendium of bioavailability enhancement via niosome technology.Pharm. Nanotechnol.202311432433810.2174/221173851166623030910432336892113
     [Google Scholar]
  59. D’AndreaA. CasoP. SalernoG. ScarafileR. De CoratoG. MitaC. Di SalvoG. SeverinoS. CuomoS. LiccardoB. EspositoN. CalabròR. GiadaF. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: A Doppler myocardial and strain imaging analysis.Br. J. Sports Med.200741314915510.1136/bjsm.2006.03017117178777
     [Google Scholar]
  60. Samrat ChauhanL.K. Potential anti-arthritic agents from indian medicinal plants.Res. Rev. J. Pharm. Pharm. Sci.2015431022
     [Google Scholar]
  61. LalitK. Phyto-pharmacological review of Coccinia indica.World J. Pharm. Pharm. Sci.20143217341745
     [Google Scholar]
  62. AhmedM.S. KhanI.J. AmanS. ChauhanS. KaurN. ShriwastavS. GoelK. SainiM. DhankarS. SinghT.G. DevJ. MujwarS. Phytochemical investigations, in-vitro antioxidant, antimicrobial potential, and in-silico computational docking analysis of Euphorbia milii Des Moul.J. Exp. Biol. Agric. Sci.202311238039310.18006/2023.11(2).380.393
     [Google Scholar]
  63. IzzatN. Abu-FarhaR. HarahshehM.M. ThiabS. A qualitative assessment of anabolic–androgenic steroid use among gym users in Jordan: motives, perception, and safety.Int. J. Legal Med.202313751421143010.1007/s00414‑023‑03046‑637355480
     [Google Scholar]
  64. SessaF. SalernoM. CipolloniL. BertozziG. MessinaG. MizioG.D. AsmundoA. PomaraC. Anabolic-androgenic steroids and brain injury: miRNA evaluation in users compared to cocaine abusers and elderly people.Aging20201215153141532710.18632/aging.10351232756006
     [Google Scholar]
  65. SivalokanathanS. MałekŁ.A. MalhotraA. The cardiac effects of performance-enhancing medications: Caffeine vs. anabolic androgenic steroids.Diagnostics202111232410.3390/diagnostics1102032433671206
     [Google Scholar]
  66. ChauhanS. Current approaches in healing of wounds in diabetes and diabetic foot ulcers.Curr. Bioact. Compd.2023193104121
     [Google Scholar]
  67. BehlT. BungauS. KumarK. ZenginG. KhanF. KumarA. KaurR. VenkatachalamT. TitD.M. VesaC.M. BarsanG. MosteanuD.E. Pleotropic effects of polyphenols in cardiovascular system.Biomed. Pharmacother.202013011071410.1016/j.biopha.2020.11071434321158
     [Google Scholar]
  68. ThapaK. KhanH. SinghT.G. KaurA. Traumatic brain injury: Mechanistic insight on pathophysiology and potential therapeutic targets.J. Mol. Neurosci.20217191725174210.1007/s12031‑021‑01841‑733956297
     [Google Scholar]
  69. RocaC.A. SchmidtP.J. RubinowD.R. Gonadal steroids and affective illness.Neuroscientist19995422723710.1177/107385849900500412
     [Google Scholar]
  70. DhankarS. MujwarS. GargN. ChauhanS. SharmaP. Kumar SharmaS. KamalM.A. RaniD.N. KumarS. SainiM. Artificial intelligence in the management of neurodegenerative disorders.CNS Neurol. Disord. Drug Targets20232311037861051
     [Google Scholar]
  71. VanbergP. AtarD. Androgenic anabolic steroid abuse and the cardiovascular system.Handb Exp Pharmacol201019541157
     [Google Scholar]
  72. RyanA.J. Anabolic steroids are fool's gold.Fed Proc1981401226828
     [Google Scholar]
  73. PetrovicA. VukadinS. SikoraR. BojanicK. SmolicR. PlavecD. WuG.Y. SmolicM. Anabolic androgenic steroid-induced liver injury: An update.World J. Gastroenterol.202228263071308010.3748/wjg.v28.i26.307136051334
     [Google Scholar]
  74. HoM.H. BhatiaN.N. BhasinS. Anabolic effects of androgens on muscles of female pelvic floor and lower urinary tract.Curr. Opin. Obstet. Gynecol.200416540540910.1097/00001703‑200410000‑0000915353950
     [Google Scholar]
  75. ChristouM.A. ChristouP.A. MarkozannesG. TsatsoulisA. MastorakosG. TigasS. Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis.Sports Med.20174791869188310.1007/s40279‑017‑0709‑z28258581
     [Google Scholar]
  76. ZellerothS. NylanderE. NybergF. GrönbladhA. HallbergM. Toxic impact of anabolic androgenic steroids in primary rat cortical cell cultures.Neuroscience201939717218310.1016/j.neuroscience.2018.11.03530500611
     [Google Scholar]
  77. StruikD. SannaF. FattoreL. The modulating role of sex and anabolic-androgenic steroid hormones in cannabinoid sensitivity.Front. Behav. Neurosci.20181224910.3389/fnbeh.2018.0024930416437
     [Google Scholar]
  78. AndrewsM.A. MageeC.D. CombestT.M. AllardR.J. DouglasK.M. Physical effects of anabolic-androgenic steroids in healthy exercising adults: A systematic review and meta-analysis.Curr. Sports Med. Rep.201817723224110.1249/JSR.000000000000050029994823
     [Google Scholar]
  79. PostnikovP.V. EfimovaY.A. ProninaI.V. Circulating MicroRNAs as a new class of biomarkers of physiological reactions of the organism to the intake of dietary supplements and drugs.MicroRNA2022111253510.2174/221153661166622042212343735466889
     [Google Scholar]
  80. GeorgiadisN. TsarouhasK. DorneJ.L.C.M. KassG.E.N. LaspaP. ToutouzasK. KoulaouzidouE.A. KouretasD. TsitsimpikouC. Cardiotoxicity of chemical substances: An emerging hazard class.J. Cardiovasc. Dev. Dis.20229722610.3390/jcdd907022635877588
     [Google Scholar]
  81. ThevisM. KuuranneT. GeyerH. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021.Drug Test. Anal.202214173010.1002/dta.319934788500
     [Google Scholar]
/content/journals/nemj/10.2174/0102506882253706240104073440
Loading
Anabolic Androgenic Steroids: A Review
NEW Emirates Medical J 5, e02506882253706 (2024); https://doi.org/10.2174/0102506882253706240104073440
/content/journals/nemj/10.2174/0102506882253706240104073440
/content/journals/nemj/10.2174/0102506882253706240104073440
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Anabolic; Anabolic androgenic steroids; Androgenic; Anti-doping; Athletes; Steroids

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test